Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Nevus × Dermatologic × Clear all

Phase

Phase NA 6 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 355 Carcinoma, Non-Small-Cell Lung 73 Neoplasm Metastasis 59 Neoplasms 47 Lymphoma, T-Cell, Cutaneous 43 Carcinoma, Renal Cell 41 Ovarian Neoplasms 37 Squamous Cell Carcinoma of Head and Neck 35 Colorectal Neoplasms 32 Breast Neoplasms 32 Skin Neoplasms 30 Stomach Neoplasms 29 Lymphoma 29 Carcinoma, Merkel Cell 27 Uveal Melanoma 26 Mycosis Fungoides 25 Lung Neoplasms 25 Triple Negative Breast Neoplasms 24 Sezary Syndrome 24 Lymphoma, Non-Hodgkin 23 Lymphoma, Follicular 22 Hodgkin Disease 22 Pancreatic Neoplasms 21 Carcinoma, Hepatocellular 20 Uterine Cervical Neoplasms 19 Lymphoma, Large B-Cell, Diffuse 19 Lymphoma, B-Cell, Marginal Zone 18 Leukemia, Lymphocytic, Chronic, B-Cell 18 Endometrial Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04364230 2024-07-16

Mel66

University of Virginia

Phase 1/2 Completed

Uveal Melanoma, Melanoma, Nevus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡